From N-of-one to series of exceptional responders: unlocking the mystery of outliers in oncology

por Rodriguez, Julieta E., Ponce-Aix, Santiago
Publicado 2023

Second-line Treatment of Non-Small Cell Lung Cancer: Focus on the Clinical Development of Dacomitinib

por Zugazagoitia, Jon, Díaz, Asunción, Jimenez, Elisabeth, Nuñez, Juan Antonio, Iglesias, Lara, Ponce-Aix, Santiago, Paz-Ares, Luis
Publicado 2017

Prognostic Value of Clinical Staging According to TNM in Patients With SCLC: A Real-World Surveillance Epidemiology and End-Results Database Analysis

por Arriola, Edurne, Trigo, José Manuel, Sánchez-Gastaldo, Amparo, Navarro, Alejandro, Perez, Coral, Crama, Leonardo, Ponce-Aix, Santiago
Publicado 2021

Analysis of Expression of Programmed Cell Death 1 Ligand 1 (PD-L1) in Malignant Pleural Mesothelioma (MPM)

por Cedrés, Susana, Ponce-Aix, Santiago, Zugazagoitia, Jon, Sansano, Irene, Enguita, Ana, Navarro-Mendivil, Alejandro, Martinez-Marti, Alex, Martinez, Pablo, Felip, Enriqueta
Publicado 2015

MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma

por Ferrer, Irene, Quintanal-Villalonga, Álvaro, Molina-Pinelo, Sonia, Garcia-Heredia, Jose Manuel, Perez, Marco, Suárez, Rocío, Ponce-Aix, Santiago, Paz-Ares, Luis, Carnero, Amancio
Publicado 2018

The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin Induction

por Quintanal-Villalonga, Álvaro, Ojeda-Márquez, Laura, Marrugal, Ángela, Yagüe, Patricia, Ponce-Aix, Santiago, Salinas, Ana, Carnero, Amancio, Ferrer, Irene, Molina-Pinelo, Sonia, Paz-Ares, Luis
Publicado 2018

Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial

por Girard, N., Ponce Aix, S., Cedres, S., Berghmans, T., Burgers, S., Toffart, A.-C., Popat, S., Janssens, A., Gervais, R., Hochstenbag, M., Silva, M., Burger, I.A., Prosch, H., Stahel, R., Xenophontos, E., Pretzenbaher, Y., Neven, A., Peters, S.
Publicado 2023

Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, control...

por Thomas, M, Ponce-Aix, S, Navarro, A, Riera-Knorrenschild, J, Schmidt, M, Wiegert, E, Kapp, K, Wittig, B, Mauri, C, Dómine Gómez, M, Kollmeier, J, Sadjadian, P, Fröhling, K -P, Huber, R M, Wolf, M
Publicado 2018

nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)

por Morgensztern, Daniel, Dols, Manuel Cobo, Ponce Aix, Santiago, Postmus, Pieter E., Bennouna, Jaafar, Fischer, Jürgen R., Juan-Vidal, Oscar, Stewart, David J., Ardizzoni, Andrea, Bhore, Rafia, Wolfsteiner, Marianne, Reck, Martin, Talbot, Denis, Govindan, Ramaswamy, Ong, Teng Jin
Publicado 2021

Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer

por Moutafi, Myrto K, Molero, Magdalena, Martinez Morilla, Sandra, Baena, Javier, Vathiotis, Ioannis A, Gavrielatou, Niki, Castro-Labrador, Laura, de Garibay, Gorka Ruiz, Adradas, Vera, Orive, Daniel, Valencia, Karmele, Calvo, Alfonso, Montuenga, Luis M, Ponce Aix, S, Schalper, Kurt A, Herbst, Roy S, Paz-Ares, Luis, Rimm, David L, Zugazagoitia, Jon
Publicado 2022

Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC

por Andric, Zoran, Gálffy, Gabriella, Cobo Dols, Manuel, Szima, Barna, Stojanovic, Goran, Petrovic, Marina, Felip, Enriqueta, Vicente Baz, David, Ponce Aix, Santiago, Juan-Vidal, Oscar, Szalai, Zsuzsanna, Losonczy, Gyorgy, Calles Blanco, Antonio, Bernabe, Reyes, García Ledo, Gema, Aguilar Hernández, Andrés, Duecker, Klaus, Zhou, Dongli, Schroeder, Andreas, Guezel, Guelseren, Ciardiello, Fortunato
Publicado 2023

Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial Cancer

por Facchinetti, Francesco, Hollebecque, Antoine, Braye, Floriane, Vasseur, Damien, Pradat, Yoann, Bahleda, Rastislav, Pobel, Cédric, Bigot, Ludovic, Déas, Olivier, Florez Arango, Juan David, Guaitoli, Giorgia, Mizuta, Hayato, Combarel, David, Tselikas, Lambros, Michiels, Stefan, Nikolaev, Sergey I., Scoazec, Jean-Yves, Ponce-Aix, Santiago, Besse, Benjamin, Olaussen, Ken A., Loriot, Yohann, Friboulet, Luc
Publicado 2023

Tumor mutational burden assessment in non-small-cell lung cancer samples: results from the TMB(2) harmonization project comparing three NGS panels

por Ramos-Paradas, Javier, Hernández-Prieto, Susana, Lora, David, Sanchez, Elena, Rosado, Aranzazu, Caniego-Casas, Tamara, Carrizo, Nuria, Enguita, Ana Belén, Muñoz-Jimenez, María Teresa, Rodriguez, Borja, Perez-Gonzalez, Urbicio, Gómez-Sánchez, David, Ferrer, Irene, Ponce Aix, Santiago, Nuñez Buiza, Ángel, Garrido, Pilar, Palacios, José, Lopez-Rios, Fernando, Garrido-Martin, Eva M, Paz-Ares, Luis
Publicado 2021

PD-1 Blockade in Anaplastic Thyroid Carcinoma

por Capdevila, Jaume, Wirth, Lori J., Ernst, Thomas, Ponce Aix, Santiago, Lin, Chia-Chi, Ramlau, Rodryg, Butler, Marcus O., Delord, Jean-Pierre, Gelderblom, Hans, Ascierto, Paolo A., Fasolo, Angelica, Führer, Dagmar, Hütter-Krönke, Marie Luise, Forde, Patrick M., Wrona, Anna, Santoro, Armando, Sadow, Peter M., Szpakowski, Sebastian, Wu, Hongqian, Bostel, Geraldine, Faris, Jason, Cameron, Scott, Varga, Andreea, Taylor, Matthew
Publicado 2020